Designated Inorganic Nonactive Ingredient Or Elemental Material Other Than Water Patents (Class 514/769)
  • Patent number: 10365597
    Abstract: An endless belt comprising a polyimide-based substrate layer. A plurality of boron nitride nanotubes are dispersed in the polyimide.
    Type: Grant
    Filed: May 26, 2016
    Date of Patent: July 30, 2019
    Assignee: XEROX CORPORATION
    Inventors: Jin Wu, Lin Ma
  • Patent number: 10290875
    Abstract: An electrode material for a secondary cell includes a porous carbon material having an absolute value of a differential value of a mass using a temperature as a parameter exceeding 0 at 360° C. and being 0.016 or more at 290° C. provided by thermally analyzing a mixture of the porous carbon material and S8 sulfur at a mass ratio of 1:2.
    Type: Grant
    Filed: May 20, 2014
    Date of Patent: May 14, 2019
    Assignee: MURATA MANUFACTURING CO., LTD.
    Inventors: Shun Yamanoi, Seiichiro Tabata, Hironori Iida, Kenji Kishimoto, Yosuke Saito, Shinichiro Yamada, Kazumasa Takeshi, Koichiro Hinokuma
  • Patent number: 10206879
    Abstract: The invention relates to solid medicinal forms containing at least one active ingredient and at least one pharmaceutically compatible, water soluble drying agent which is selected from the group consisting of trimagnesium dicitrate and/or calcium chloride, the solid medicinal form having a drying loss of at most 6% and a relative equilibrium moisture content of 25% or less. The invention also relates to solid medicinal forms containing a moisture-sensitive active ingredient and trimagnesium dicitrate.
    Type: Grant
    Filed: September 15, 2017
    Date of Patent: February 19, 2019
    Assignee: Losan Pharma GmbH
    Inventors: Peter Gruber, Dirk Spickermann
  • Patent number: 10093072
    Abstract: Graphene reinforced materials and related methods of manufacture are provided. The graphene reinforced materials include graphene sheet or scroll, graphene-polymer sheet or scroll, and graphene-carbon sheet or scroll, each having material properties that are attractive across a broad range of applications and industries. The graphene reinforced materials generally include monolayer or multilayer graphene that is synthesized by annealing a catalyst substrate within a CVD chamber, introducing a hydrocarbon gas as a carbon source with the CVD chamber to form a layer of graphene on the catalyst substrate, detaching the catalyst substrate from the layer of graphene, and rolling the layer of graphene onto itself to form a scroll, optionally with the addition of a polymer layer or carbonized layer on the graphene layer.
    Type: Grant
    Filed: March 18, 2014
    Date of Patent: October 9, 2018
    Assignee: UT-Battelle, LLC
    Inventors: Ivan V. Vlassiouk, Ilia N. Ivanov, Panagiotis G. Datskos
  • Patent number: 9399589
    Abstract: Glycine is an organic compound that can be used in the making of a synthetic base that obviates all the drawbacks of strong bases such as sodium hydroxide. The new compound is made by dissolving glycine in water and adding calcium hydroxide at a molar ration of about 1:1. Next, sodium percarbonate is dissolved in the solution to produce the new compound, which can be referred to as glycine hydroxide.
    Type: Grant
    Filed: December 30, 2014
    Date of Patent: July 26, 2016
    Assignee: Green Products & Technologies, L.L.C
    Inventor: John T. MacDonald
  • Patent number: 9326996
    Abstract: The present invention relates to the use of xenon in the preparation of a medicament for preventing and/or alleviating one or more anesthetic-induced neurological deficits in a neonatal subject. The present invention further relates to combinations of xenon and sevoflurane, and use thereof as preconditioning agents for administration prior to hypoxic-ischaemic injury.
    Type: Grant
    Filed: February 10, 2015
    Date of Patent: May 3, 2016
    Inventors: Nicholas Peter Franks, Mervyn Maze
  • Publication number: 20150139911
    Abstract: A method for direct therapeutic treatment of myocardial tissue in a localized region of a heart having a pathological condition. The method includes identifying a target region of the myocardium and applying material directly and substantially only to at least a portion of the myocardial tissue of the target region. The material applied results in a physically modification the mechanical properties, including stiffness, of said tissue. Various devices and modes of practicing the method are disclosed for stiffening, restraining and constraining myocardial tissue for the treatment of conditions including myocardial infarction or mitral valve regurgitation.
    Type: Application
    Filed: December 4, 2014
    Publication date: May 21, 2015
    Inventors: William P. Santamore, Jeanne M. Lesniak
  • Publication number: 20150118310
    Abstract: Provided is an organic-inorganic hybrid composite of a polymerized cyclic nitroxide radical compound and inorganic nanoparticles. Such a composite is capable, for example, of maintaining a stable nanoparticle shape in gastric fluid, and can be used by itself or as a carrier for delivery of another drug to the intestines.
    Type: Application
    Filed: February 6, 2013
    Publication date: April 30, 2015
    Inventors: Yukio Nagasaki, Yutaka Ikeda, Toru Yoshitomi, Tatsuya Yaguchi, Mayo Yamashita, Md. Amran Hossain, Tomoki Yoshinari, Atsushi Ueda, Aki Hirayama
  • Publication number: 20150119469
    Abstract: The invention proposes a kit and formulations for biomimetic deposition of apatite on teeth from a partially elastic shaped body comprising an envelope, whereby the shaped body a) comprises at least one mineralization matrix containing a gel that comprises water-soluble phosphates or phosphates that can be hydrolysed to form water-soluble phosphate ions and has a pH value of 2 to 8, optionally fluorides, and b) the at least one or a second mineralization matrix comprises a second gel having a pH value of 3.5 to 14 comprising calcium ions or compounds releasing calcium ions. Moreover, the method for producing the formulation and the use thereof for the deposition of apatite, in particular of needle-shaped fluorapatite crystallites, is claimed. Using the formulations according to the invention, it is feasible to deposit more than or equal to 1 ?m apatite, in particular fluorapatite, on tooth surfaces in order to seal or brighten porous tooth surfaces.
    Type: Application
    Filed: September 9, 2014
    Publication date: April 30, 2015
    Inventors: Susanne BUSCH, Andreas UTTERODT, Michael GERLACH
  • Patent number: 9018236
    Abstract: Described herein are cyclodextrin-stabilized microemulsion systems useful for increasing the solubility, stability, bioavailability, or safety of an active agent for delivery to the skin. The microemulsions may reduce the occurrence of skin irritation or odor upon application.
    Type: Grant
    Filed: March 14, 2013
    Date of Patent: April 28, 2015
    Assignee: Precision Dermatology, Inc.
    Inventors: Mark W. Trumbore, Pinaki Ranjan Majhi, Dinen Divyang Shah
  • Patent number: 8999938
    Abstract: The ophthalmic drug delivery vehicles provide comfort and compliance; drug solubility, residence time and permeability; and reduce side effects. In addition, the delivery vehicle can be slightly modified to provide an artificial tear formulation.
    Type: Grant
    Filed: June 21, 2013
    Date of Patent: April 7, 2015
    Assignee: GNT LLC
    Inventor: Gerald Horn
  • Patent number: 8986735
    Abstract: A solid dosage form containing a taste masked active agent is provided. The solid dosage form may be provided as a water soluble film that is disintegrable in the oral cavity to deliver and release the taste masked active agent. The disintegrable film includes at least one water soluble polymer and a taste masked ketoprofen active. Also provided are methods for preparing the solid dosage form and for using the solid dosage to administer an effective dosage of an active agent, such as ketoprofen, into the oral cavity for absorption.
    Type: Grant
    Filed: March 15, 2007
    Date of Patent: March 24, 2015
    Assignee: Novartis AG
    Inventors: Alexander M Schobel, Shyam S Vangala
  • Publication number: 20150079173
    Abstract: Formulations have been developed for pulmonary delivery to treat or reduce the infectivity of diseases such as viral infections, especially tuberculosis, SARS, influenza and respiratory synticial virus in humans and hoof and mouth disease in animals, or to reduce the symptoms of allergy or other pulmonary disease. Formulations for pulmonary administration include a material that significantly alters physical properties such as surface tension and surface elasticity of lung mucus lining fluid, which may be isotonic saline and, optionally, a carrier. The formulation may be administered as a liquid solution, suspension, aerosol, or powder where the particles consist basically of an osmotically active solute. Drugs, especially antivirals or antibiotics, may optionally be included with the formulation. These may be administered with or incorporated into the formulation.
    Type: Application
    Filed: October 21, 2013
    Publication date: March 19, 2015
    Applicant: PULMATRIX, INC.
    Inventors: David A. EDWARDS, Jonathan Chun-Wah MAN, Jeffrey P. KATSTRA, Robert W. CLARKE
  • Publication number: 20150080479
    Abstract: A composition for enteric hard capsules and an enteric hard capsule prepared using the composition. The composition includes a water-soluble divalent base and an alkaline agent. The enteric hard capsule has high transparency and delaying effects of separation of salt during storage.
    Type: Application
    Filed: March 26, 2012
    Publication date: March 19, 2015
    Applicant: SAMSUNG FINE CHEMICALS CO., LTD.
    Inventors: Jin Ryul Son, Eun Hee Park, Hyon Ho Baek
  • Publication number: 20150072017
    Abstract: Osteogenic implants, carriers and concentrates are described, along with methods of making and using the same. The implants include a carrier and, optionally, an osteoinductive agent. The carrier includes a mineral component, a binder and, optionally, a collagen additive, while the osteoinductive agent may be a protein such as a bone morphogenetic protein.
    Type: Application
    Filed: September 9, 2013
    Publication date: March 12, 2015
    Applicant: Olympus Biotech Corporation
    Inventors: Hyun Kim, Shinichi Torii, Margaret M. Worden, Tetsuro Ogawa, Nozomi Komatsu
  • Patent number: 8974769
    Abstract: The present invention proposes a magnetic nanocomposite with multi-biofunctional groups, which comprises a core and a shell wrapping the core, wherein the core contains magnetic nanoparticles, and wherein the shell is made of a conductive polymer with multi-biofunctional groups where a medicine, an antibody or a fluorescent label can be attached.
    Type: Grant
    Filed: May 4, 2010
    Date of Patent: March 10, 2015
    Assignee: Chang Gung University
    Inventors: Mu-Yi Hua, Hung-Wei Yang, Rung-Ywan Tsai, Kuo-Chen Wei, Pin-Yuan Chen, Hao-Li Liu
  • Publication number: 20150051300
    Abstract: An antiinfective-free formulation for prophylactic treatment of mastitis in dry cows comprises a seal formulation, having approximately 65% by weight of bismuth sub-nitrate in a gel based on aluminum stearate. The seal formulation is prepared by adding the bismuth sub-nitrate to the gel base in at least two separate stages.
    Type: Application
    Filed: February 19, 2014
    Publication date: February 19, 2015
    Applicant: Bimeda Research & Development Limited
    Inventors: Vincent McNally, James Patrick Morgan
  • Publication number: 20150045450
    Abstract: A process for making nanoparticles of biocompatible materials is described, wherein an aqueous reaction mixture comprising a metal ion, a nucleobase, an oxidant, and water, is provided along with temperature conditions to directly form within the reaction mixture, a stable dispersion of nanoparticles. Biocompatible nanoparticles comprised of cerium or iron as the metal ion, and a purine and/or a pyrimidine as the nucleobase, are described.
    Type: Application
    Filed: August 11, 2014
    Publication date: February 12, 2015
    Applicant: CERION, LLC
    Inventors: ASHLEY RENÉE VERSAGGI, WENDI ANN COSTANZO, KENNETH JOSEPH REED
  • Publication number: 20150038593
    Abstract: The present invention is directed to methods of disaggregating nanodiamond clusters, especially those clusters typically produced from detonation syntheses, the nanodiamond particles and dispersions produced from these disaggregation processes, and compositions derived from these nanodiamond particles and dispersions.
    Type: Application
    Filed: May 7, 2012
    Publication date: February 5, 2015
    Applicant: Drexel University
    Inventors: Yury Gogotsi, Vadym Mochalin
  • Publication number: 20150024044
    Abstract: Gastric resistant film-forming compositions are described herein. The composition comprises a gastric resistant natural polymer, a film-forming natural polymer, and optionally a gelling agent. Suitable gastric resistant natural polymers include polysaccharides such as pectin and pectin-like polymers. The film-forming composition can be used to prepare soft or hard shell gelatin capsules which can encapsulate a liquid or semi-solid fill material or a solid tablet (Softlet®) comprising an active agent and one or more pharmaceutically acceptable excipients. Alternatively, the composition can be administered as a liquid with an active agent dissolved or dispersed in the composition. The compositions are not only gastric resistant but may also prevent gastric reflux associated with odor causing liquids, such as fish oil or garlic oil, encapsulated in a unit dosage form and esophageal irritation due to the reflux of irritant drugs delivered orally.
    Type: Application
    Filed: October 6, 2014
    Publication date: January 22, 2015
    Inventor: Nachiappan Chidambaram
  • Patent number: 8936809
    Abstract: A method for treating prostate related diseases in a subject, the method comprising i) optionally administering to subject an initial boost dose of one or more active substances and/or prodrugs, and ii) administering locally into the prostate a controlled release pharmaceutical composition comprising one or more active substances in a biodegradable ceramic carrier. The biodegradable hydrating ceramic may be selected from the group consisting of non-hydrated or hydrated calcium sulphate, calcium phosphate, calcium carbonate, calcium fluoride, calcium silicate, magnesium sulphate, magnesium phosphate, magnesium carbonate, magnesium fluoride, magnesium silicate, barium sulphate, barium phosphate, barium carbonate, barium fluoride, barium silicate, or mixtures thereof. In a specific embodiment, the biodegradable hydrating ceramic is non-hydrated or hydrated calcium sulphate.
    Type: Grant
    Filed: March 31, 2006
    Date of Patent: January 20, 2015
    Assignee: Lidds AB
    Inventors: Hans Lennernäs, Bo Lennernäs, Jonas Hugosson, Niklas Axén
  • Publication number: 20150010652
    Abstract: Hydrotalcite particles having an extremely small average secondary particle diameter and a production process therefor. A resin composition comprising hydrotalcite fine particles and having excellent transparency and a molded article thereof. The hydrotalcite fine particles have an average secondary particle diameter measured by a dynamic light scattering method of 5 to 100 nm.
    Type: Application
    Filed: March 25, 2013
    Publication date: January 8, 2015
    Applicant: Kyowa Chemical Industry Co., Ltd.
    Inventors: Yusuke Kurogi, Tsukasa Nakamura, Shigeo Miyata
  • Publication number: 20150011655
    Abstract: The invention relates to a method of synthesis of substantially pure nanoparticles in a continuous-flow system, in which a precursor substance solution undergoes reduction reaction using a reducing agent solution and nanoparticles are produced, wherein the reduction reaction is terminated by adding an agent neutralizing the reducing agent and a stable nanoparticle colloid is produced. In the method of the invention a need for using surfactants or other organic molecules for nanoparticle stabilization has been eliminated.
    Type: Application
    Filed: September 12, 2014
    Publication date: January 8, 2015
    Inventors: Rafal JURCZAKOWSKI, Adam LEWERA, Pawel KULBOKA
  • Publication number: 20150004209
    Abstract: A metal matrix has a biocompatible solid lubricant in at least a portion of its surface and the solid lubricant functions to protect the interior of the metal matrix and minimize the friction coefficient and related wear induced damage at the articulating surface of the metal device. The lubricated biocompatible metal device is made of materials compatible for in vivo and ex vivo applications in order to minimize wear induced degradation as well as metal ion release. The lubricated biocompatible metal device is suited for use as medical implants.
    Type: Application
    Filed: February 11, 2013
    Publication date: January 1, 2015
    Applicant: WASHINGTON STATE UNIVERSITY
    Inventors: Susmita Bose, Amit Bandyopadhyay
  • Publication number: 20150005392
    Abstract: Compositions of, methods of making, and methods of using alkaline earth phosphate bone cements are disclosed. A bone cement composition includes a powder comprising a basic source of calcium, magnesium, or strontium, a setting solution comprising H3PO4 and a buffer, and a biocompatible polymer that is incorporated into the setting solution. The powder is mixed with the setting solution to form a bone cement paste that either (a) sets into a hardened mass, or (b) is irradiated with electromagnetic radiation to form dry powders, the dry powders then being mixed with a second setting solution to form a radiation-assisted bone cement paste that sets into a hardened mass.
    Type: Application
    Filed: January 31, 2013
    Publication date: January 1, 2015
    Applicant: THE UNIVERSITY OF TOLEDO
    Inventors: Sarit B. Bhaduri, Huan Zhou, Anand K. Agarwal, Vijay K. Goel
  • Publication number: 20150004201
    Abstract: The present invention relates to improved powderous formulations of organic acids or esters having an aromatic ring system, as well as to the production of such formulations.
    Type: Application
    Filed: February 6, 2013
    Publication date: January 1, 2015
    Inventors: Martin Gadient, Thomas Lindemann, Karl Manfred Voelker, Kai Urban, Stefanie Kirchen, Andreas Keller
  • Patent number: 8920796
    Abstract: An adsorbent for an oral administration, comprising a surface-modified spherical activated carbon wherein an average diameter is 0.01 to 1 mm, a specific surface area determined by a BET method is 700 m2/g or more, a volume of pores having a pore diameter of 7.5 to 15000 nm is from 0.25 mL/g to 1.0 mL/g, a total amount of acidic groups is 0.30 to 1.20 meq/g, and a total amount of basic groups is 0.20 to 0.7 meq/g, is disclosed.
    Type: Grant
    Filed: October 22, 2004
    Date of Patent: December 30, 2014
    Assignee: Kureha Corporation
    Inventors: Naohiro Sonobe, Takashi Wakahoi
  • Publication number: 20140378391
    Abstract: The ophthalmic drug delivery vehicles provide comfort and compliance; drug solubility, residence time and permeability; and reduce side effects. In addition, the delivery vehicle can be slightly modified to provide an artificial tear formulation.
    Type: Application
    Filed: June 21, 2013
    Publication date: December 25, 2014
    Inventor: Gerald Horn
  • Publication number: 20140377196
    Abstract: A user controlled, customizable topical skin care product comprising a topical skin care product, at least one separate ingredient that may be combined with said product, and a means for combining said product and said ingredient. This device allows users to customize the skin care product's product-to-ingredient ratio.
    Type: Application
    Filed: June 20, 2013
    Publication date: December 25, 2014
    Inventor: Rizwan Watto
  • Publication number: 20140370072
    Abstract: Provided herein is a prohealing piezoelectric coating and the method of making and using the same.
    Type: Application
    Filed: September 3, 2014
    Publication date: December 18, 2014
    Inventors: Syed Faiyaz Ahmed Hossainy, Mikael Trollsas, Lothar Walter Kleiner
  • Patent number: 8906504
    Abstract: The present invention relates to pigments comprising a substrate and, applied thereto, an iron-containing coating comprising metallic iron, process for the preparation of the pigments according to the invention, and the use thereof.
    Type: Grant
    Filed: June 16, 2006
    Date of Patent: December 9, 2014
    Assignee: Merck Patent GmbH
    Inventors: Helge Bettina Kniess, Gerhard Pfaff
  • Publication number: 20140356309
    Abstract: The present invention relates to a use of an acid in a manufacture of an organopolysiloxane through a condensation reaction of a silicon-containing compound containing a silicon-bonded hydroxyl group and a silicon-containing compound containing a silicon-bonded aminoxy group. Particularly, the present invention relates to a low-odor composition including such an organopolysiloxane. The composition according to the present invention can have little odor caused by a by-product produced via the condensation reaction described above.
    Type: Application
    Filed: December 4, 2012
    Publication date: December 4, 2014
    Inventors: Masaru Ozaki, Seiji Hori, Takatoshi Toyama, Kazuhiko Kojima, Tsunehito Sugiura
  • Patent number: 8900602
    Abstract: Disclosed is an orally rapidly disintegrating tablet which has a good texture and taste in the oral cavity, such a sufficient hardness as not giving any worry of being chipped or dusted during production or transportation and good disintegrating properties in the oral cavity. The orally rapidly disintegrating tablet, which has a good texture and taste, an appropriate hardness, and good disintegrating properties, can be produced by using a composition, which is prepared by dispersing, by spray-drying, an inorganic excipient and starch(es) in complex particles composed of mannitol and xylitol, in an orally rapidly disintegrating tablet.
    Type: Grant
    Filed: August 11, 2010
    Date of Patent: December 2, 2014
    Assignee: Fuji Chemical Industry Co., Ltd.
    Inventors: Keiichi Fujiwara, Tadashi Fukami, Haruka Koizumi
  • Publication number: 20140341957
    Abstract: A stable, aqueous composition containing a crosslinked, nonionic, amphiphilic polymer capable of forming a yield stress fluid in the presence of a surfactant is disclosed. The crosslinked, nonionic amphiphilic polymer is prepared by dispersion polymerization in the presence of a stabilizing polymer. The yield stress fluid is capable of suspending insoluble materials in the form of particulates and/or droplets requiring suspension or stabilization.
    Type: Application
    Filed: September 13, 2012
    Publication date: November 20, 2014
    Applicant: LUBRIZOL ADVANCED MATERIALS, INC.
    Inventors: Wei-Yeih Yang, Krishnan Chari, Shui-Jen Raymond Hsu, Prachur Bhargava
  • Publication number: 20140342019
    Abstract: Methods preparing a personal care substance in fluid form from gemstones or gold. The gemstones or gold are comminuted and dissolved. Solvent is removed by distillation, leaving an oily residue usable in the personal care substance. The personal care substance may include fulvates and humates, or dissolved gold. The personal care substance may comprise an ozonated oil.
    Type: Application
    Filed: May 13, 2014
    Publication date: November 20, 2014
    Inventors: Tiffany Andersen, Robert Allen Barlett
  • Patent number: 8889745
    Abstract: Fibrous calcium pyrophosphate particles with a unique fibrous nanostructure are disclosed. The invention includes a composition, comprising fibrous particles, wherein the fibrous particles include fibers and the fibers include calcium and pyrophosphate. Also included are methods for making calcium pyrophosphate particles wherein solutions of calcium salt and pyrophosphate salt are combined to form the particles. Pharmaceutical compositions and methods for treating a patent using the disclosed particles are also described.
    Type: Grant
    Filed: November 30, 2011
    Date of Patent: November 18, 2014
    Assignee: Nanunanu Ltd.
    Inventors: Liam M. Grover, Jake E. Barralet
  • Publication number: 20140336273
    Abstract: The present invention relates to a highly pure, anhydrous sodium carbonate having a low pore content for use in pharmaceutical formulations and in the foods industry. Furthermore, a novel process for the preparation of this sodium carbonate is provided.
    Type: Application
    Filed: November 10, 2012
    Publication date: November 13, 2014
    Applicant: Merck Patent GmbH
    Inventors: Jens Klatyk, Hans-Kurt Peth, Thorsten Wedel, Guenter Moddelmog
  • Publication number: 20140335034
    Abstract: A consumer product comprises silane-modified oil comprising a hydrocarbon chain selected from the group consisting of: a saturated oil, an unsaturated oil, and mixtures thereof; and at least one hydrolysable silyl group covalently bonded to the hydrocarbon chain. The consumer product further comprises a preservative.
    Type: Application
    Filed: May 8, 2014
    Publication date: November 13, 2014
    Applicant: The Procter & Gamble Company
    Inventors: Rajan Keshav PANANDIKER, Beth Ann SCHUBERT, John August WOS, Luke Andrew ZANNONI, Nathan Ray Whitely
  • Patent number: 8883221
    Abstract: Micronutrient combination product, wherein the micronutrient combination product comprises zeaxanthin, lutein, zinc and copper.
    Type: Grant
    Filed: December 17, 2004
    Date of Patent: November 11, 2014
    Assignee: Bausch & Lomb Incorporated
    Inventors: Guenter Bellmann, Gudrun Claus-Herz
  • Publication number: 20140328907
    Abstract: Provided is a platform for entrapment within alumina sol-gel carriers of labile biologically active materials such as proteins, therapeutic enzymes, enzymes of industrial relevance, antigens, and small molecules for achieving successful and efficient protective storage, protection from harsh environmental conditions such as heat, pH and chemicals, delivery to site and subsequent treatment and/or vaccination against diseases against which the active agents are targeted.
    Type: Application
    Filed: May 1, 2014
    Publication date: November 6, 2014
    Applicant: Yissum Research Development Company of the Hebrew University of Jerusalem Ltd.
    Inventors: David AVNIR, Abraham RUTENBERG, Vladimir V. VINOGRADOV
  • Publication number: 20140322282
    Abstract: Ultra-fine microcrystalline cellulose compositions are disclosed which comprise co-attrited microcrystalline cellulose and a hydrocolloid. The compositions have a mean particle size of less than 10 microns. The compositions are prepared by subjecting a high solids mixture of microcrystalline cellulose and a hydrocolloid to high shear forces in the presence of an anti slip agent preferably an aqueoussolution of an inorganic salt. The compositions are especially useful in food, pharmaceutical and cosmetic and industrial applications.
    Type: Application
    Filed: July 10, 2014
    Publication date: October 30, 2014
    Inventors: Domingo C. Tuason, Jose Amundarain, Gregory R. Krawczyk, Edward Selinger, William R. Blakemore, James J. Modliszewski, Joseph Lee, Frank Messick
  • Publication number: 20140309312
    Abstract: A method of synthesizing for an iron based magnetic composite material includes the steps of stirring together potassium hydroxide, iron (II, III) oxide, and water. The method also includes the steps of heating the resulting Fe3O4—KOH mixture for a predetermined amount of time. Further, the method includes the step of heating the Fe3O4—KOH mixture until consecutive measurements of the Fe3O4—KOH mixture are within 10% of each other. Also included in the method if adding calcium hypochlorite and mixing until a magnetic Fe(VI)/Fe3O4 composite material is formed. Additionally, the method involves preparing and analyzing the magnetic Fe(VI)/Fe3O4 composite material to determine the amount of ferrate synthesized during from the method.
    Type: Application
    Filed: April 14, 2014
    Publication date: October 16, 2014
    Inventor: Bo Fan
  • Publication number: 20140308239
    Abstract: Featured herein are vehicle formulations and formulations containing a chimeric cytokine designed for e.g., ocular delivery.
    Type: Application
    Filed: March 13, 2014
    Publication date: October 16, 2014
    Applicant: ELEVEN BIOTHERAPEUTICS, INC.
    Inventors: Gregory Zarbis-Papastoitsis, Patricia Lowden, Byeong Chang
  • Publication number: 20140294948
    Abstract: The invention relates in one aspect to a composition, specifically a jelly, the use of which composition as an auxiliary means is to ease the taking of oral medication in solid form, which composition comprises iota-carrageenan as a jellifying agent and citric acid as a salivating agent, characterized in that the composition further comprises maltodextrin. In another aspect, the composition comprises a calcium sequestrant for adjusting Ca-ion activity of the composition. In one embodiment, the composition comprises iota-carrageenan in 0.7-1.0% in mass, citric acid in 0.06-0.07% in mass, maltodextrin in 1.5% in mass, all relative to the total mass of the composition, and an amount of a calcium sequestrant such that the Ca-ion activity of the composition is between 20 ppm and 80 ppm.
    Type: Application
    Filed: April 2, 2014
    Publication date: October 2, 2014
    Applicant: PAXTREE LTD
    Inventor: Ron BRUIJNS
  • Publication number: 20140294909
    Abstract: A layer-by-layer (LbL) system, which alternately ionically complexes anionic AuNPs to two unique cationic polymers (disulfide-reducible and hydrolytically degradable) and two anionic nucleic acids, is disclosed.
    Type: Application
    Filed: October 12, 2012
    Publication date: October 2, 2014
    Applicant: THE JOHNS HOPKINS UNIVERSITY
    Inventors: Jordan J. Green, Corey J. Bishop, Daniel Peng, Stephany Yi Tzeng
  • Publication number: 20140288188
    Abstract: This invention discloses a process for stabilising an aqueous mineral preparation comprising a step of adding at least one aldehyde-containing and/or aldehyde-releasing and/or phenolic and/or isothiazoline biocide to said aqueous mineral preparation.
    Type: Application
    Filed: November 22, 2012
    Publication date: September 25, 2014
    Inventors: Nicola Di Maiuta, Patrick Schwarzentruber
  • Publication number: 20140275286
    Abstract: In various embodiments a carbon nanotube molecular rebar formulation comprising a specific composition is disclosed. The composition comprises discrete carbon nanotubes that have at least a portion of the carbon nanotubes with a number average (ratio of number average contour length to end to end length) of greater than 1.1 and up to about 3. These discrete carbon nanotubes having the specified ratio of number average (tube contour length (TCL) to number average tube end-end length) ratio are not only discrete (separated) from one another, but are also controlled in their alignment such that processability and mechanical strength properties are both enhanced. Utility of the molecular rebar composition includes, but is not limited to improved composites, engineered materials, foams, sealants, coatings and adhesives, energy devices such as photovoltaics, batteries and capacitors, sensors and separation membranes.
    Type: Application
    Filed: March 13, 2014
    Publication date: September 18, 2014
    Applicant: Molecular Rebar Design, LLC
    Inventors: Clive P. Bosnyak, Kurt W. Swogger
  • Publication number: 20140275287
    Abstract: The present invention relates to water soluble and completely absorbable and/or physiologically degradable hemostatic compositions having a wax or wax-like base effective for use in tamponade hemostasis of bone or cartilage.
    Type: Application
    Filed: November 1, 2012
    Publication date: September 18, 2014
    Applicant: ABYRX, INC.
    Inventors: David Knaack, John Pacifico, Marci Wirtz, Richard L. Kronenthal, Frank Do, Aniq Darr
  • Publication number: 20140248364
    Abstract: The compositions and methods of the disclosure particularly target the divalent metal transporter expressed on olfactory nerve terminals to transport divalent cation-coated or cation-containing nanoparticles to all regions of brain. It has been found that such divalent cation-containing nanoparticles, including those nanoparticles comprising manganese have affinity for the metal transport receptor proteins. Although this receptor has particular affinity for manganese, it is contemplated that other divalent ions, including magnesium, calcium, and the like may also be bound to such receptors leading to transport of the nanoparticles into the intracellular cytoplasm. Nanoparticles have been developed, therefore, as vehicles for parenteral delivery of genes, proteins and drugs.
    Type: Application
    Filed: September 14, 2012
    Publication date: September 4, 2014
    Inventors: Juan Sanchez-Ramos, Vasyl Sava, Shijie Song, Shyam S. Mohapatra, Subhra Mohapatra
  • Publication number: 20140248214
    Abstract: Methods of using a surface active block copolymer to disperse graphene in an aqueous medium, such dispersions which can be subsequently separated and processed for a range of end-use applications, including biomedical applications.
    Type: Application
    Filed: March 14, 2013
    Publication date: September 4, 2014
    Inventors: Mark C. Hersam, Jung-Woo T. Seo, Alexander A. Green, Alexander L. Antaris